🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

The Effect of PIOMI and Chronobiological Nutrition on Readiness for Feeding, Full Transition to Oral Feeding and Body Weight

RecruitingNAAges 29 Weeks - 33 WeeksAllAydin Adnan Menderes University
NCT07306793 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This is a randomized controlled experimental study evaluating the effects of oral motor intervention and chronobiological approach to feeding model applied to preterm infants on feeding readiness, transition to total oral feeding and body weight.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Preterm infants with a postnatal age of 29-33 weeks, * Whose vital signs and clinical condition have been stable for at least 24 hours, * Whose APGAR score at 1 and 5 minutes (Activity-Pulse-Grimace-Appearance-Respiration) is 4 or higher. Exclusion Criteria: * Infants with major congenital anomalies (such as congenital heart disease, cleft palate, cleft lip) or birth trauma, * Infants with RDS, * Infants diagnosed with asphyxia, * Infants with intraventricular hemorrhage, * Infants with Neonatal Withdrawal Syndrome, * Infants with Fetal Alcohol Syndrome, * Infants included in the study group who develop any complications or whose stable condition deteriorates during the follow-up period, * Infants with feeding intolerance or who are interrupted from feeding for more than 48 hours, * Infants who develop sepsis, * Infants who develop necrotizing enterocolitis, * Infants receiving mechanical ventilation support, * Infants who receive narcotic analgesia or sedation,
💊

What it tests

  • PIOMI study group
  • Nutrition Study Group with a Chronobiological Approach
  • Control group
📍

Where

1 site
Aydın Adnan Menderes University, Faculty of Nursing, Department of Child Health and Disease Nursing
Aydin, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy